Immunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above

NCT05664932 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant SARS-CoV-2 Vaccine (CHO Cell) LYB001
BIOLOGICAL: ZF2001

Sponsor

Guangzhou Patronus Biotech Co., Ltd.

Collaborators

[object Object]